Literature DB >> 26481727

Contrast-enhanced ultrasound of embolic consolidations in patients with pulmonary embolism: A pilot study.

Sybille Bartelt1, Corinna Trenker2, Christian Görg1, Albrecht Neesse3.   

Abstract

PURPOSE: To analyze and describe the contrast-enhanced ultrasound (CEUS) patterns of peripheral lung lesions in patients with pulmonary embolism (PE) confirmed on CT angiography or lung scintigraphy.
METHODS: CEUS had been performed on 35 patients with peripheral lung lesions detected on gray-scale imaging and confirmed as PE. The following data were evaluated retrospectively: (1) accumulation of contrast medium (absent or present), (2) differentiation between pulmonary arterial (PA) and bronchial arterial blood supply, and (3) contrast-enhancement pattern (absent/nonhomogeneous or homogeneous). A CEUS pattern of absent or nonhomogeneous enhancement was suspicious (ie, typical) of embolic consolidations (EC), whereas a pattern of homogeneous PA enhancement was considered to be atypical of EC.
RESULTS: Peripheral lesions showed a CEUS pattern suspicious of EC in 80% of the patients, with no enhancement in 40% and nonhomogeneous enhancement in another 40%. A CEUS pattern of homogeneous PA enhancement, atypical of EC, was identified in the remaining 20% of the patients. Pulmonary lesions larger than 1 cm showed vascularization more often than smaller lesions did (p < 0.001).
CONCLUSIONS: Peripheral lung lesions in patients with confirmed PE show a CEUS pattern of absent or nonhomogeneous contrast enhancement for suspicious EC. Further prospective studies are required to verify the diagnostic accuracy of CEUS for EC.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  chest ultrasonography; contrast-enhanced ultrasonography; pleurisy; pulmonary embolism

Mesh:

Substances:

Year:  2015        PMID: 26481727     DOI: 10.1002/jcu.22313

Source DB:  PubMed          Journal:  J Clin Ultrasound        ISSN: 0091-2751            Impact factor:   0.910


  7 in total

Review 1.  [Standardized contrast-enhanced ultrasound (CEUS) in clinical acute and emergency medicine and critical care (CEUS Acute) : Consensus statement of DGIIN, DIVI, DGINA, DGAI, DGK, ÖGUM, SGUM and DEGUM].

Authors:  Guido Michels; Rudolf Horn; Andreas Helfen; Andreas Hagendorff; Christian Jung; Beatrice Hoffmann; Natalie Jaspers; Horst Kinkel; Clemens-Alexander Greim; Fabian Knebel; Johann Bauersachs; Hans-Jörg Busch; Daniel Kiefl; Alexander O Spiel; Gernot Marx; Christoph F Dietrich
Journal:  Med Klin Intensivmed Notfmed       Date:  2022-02       Impact factor: 0.840

2.  Clinical Value of Ultrasonography in Diagnosis of Pulmonary Embolism in Critically Ill Patients.

Authors:  Ran Zhu; Xiao-Chun Ma
Journal:  J Transl Int Med       Date:  2017-12-29

3.  Perfusion Patterns of Peripheral Pulmonary Lesions in COVID-19 Patients Using Contrast-Enhanced Ultrasound (CEUS): A Case Series.

Authors:  Ehsan Safai Zadeh; Björn Beutel; Christoph Frank Dietrich; Corinna Ulrike Keber; Katharina Paulina Huber; Christian Görg; Corinna Trenker
Journal:  J Ultrasound Med       Date:  2021-01-18       Impact factor: 2.754

4.  Contrast-Enhanced Ultrasonography: A Promising Method for Blood Flow and Perfusion Evaluation in Critically Ill Patients.

Authors:  Jun Wu; De-Chang Chen
Journal:  Chin Med J (Engl)       Date:  2018-05-20       Impact factor: 2.628

5.  Contrast enhanced ultrasound (CEUS) to assess pleural pulmonal changes in severe COVID-19 infection: First results.

Authors:  E M Jung; C Stroszczynski; F Jung
Journal:  Clin Hemorheol Microcirc       Date:  2020       Impact factor: 2.375

Review 6.  Contrast-enhanced ultrasound of pediatric lungs.

Authors:  Vasileios Rafailidis; Savvas Andronikou; Hans-Joachim Mentzel; Maciej Piskunowicz; Judy H Squires; Carol E Barnewolt
Journal:  Pediatr Radiol       Date:  2021-05-12

7.  Multi-organ point-of-care ultrasound for detection of pulmonary embolism in critically ill COVID-19 patients - A diagnostic accuracy study.

Authors:  Arthur Lieveld; M L A Heldeweg; J M Smit; M E Haaksma; L Veldhuis; R S Walburgh-Schmidt; J Twisk; P W B Nanayakkara; L Heunks; P R Tuinman
Journal:  J Crit Care       Date:  2022-02-02       Impact factor: 4.298

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.